Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial
Clinical Research in Cardiology · 2025
DOI: 10.1007/s00392-024-02487-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Gabor G Toth und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart Center Graz, Medical University Graz, Graz, Austria. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Conservative Treatment, Ischemia, Coronary Artery Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
INCORPORATE trial was designed to evaluate whether default coronary-angiography (CA) and ischemia-targeted revascularization is superior compared to a conservative approach for patients with treated critical limb ischemia (CLI). Registered at clinicaltrials.gov (NCT03712644) on October 19, 2018.
Background
Severe peripheral artery disease is associated with increased cardiovascular risk and poor outcomes.
Methods
INCORPORATE was an open-label, prospective 1:1 randomized multicentric trial that recruited patients who had undergone successful CLI treatment. Patients were randomized to either a conservative or invasive approach regarding potential coronary artery disease (CAD). The conservative group received optimal medical therapy alone, while the invasive group had routine CA and fractional flow reserve-guided revascularization. The primary endpoint was myocardial infarction (MI) and 12-month mortality.
Results
Due to COVID-19 pandemic burdens, recruitment was halted prematurely. One hundred eighty-five patients were enrolled. Baseline cardiac symptoms were scarce with 92% being asymptomatic. Eighty-nine patients were randomized to the invasive approach of whom 73 underwent CA. Thirty-four percent had functional single-vessel disease, 26% had functional multi-vessel disease, and 90% achieved complete revascularization. Conservative and invasive groups had similar incidences of death and MI at 1 year (11% vs 10%; hazard ratio 1.21 [0.49–2.98]). Major adverse cardiac and cerebrovascular events (MACCE) trended for hazard in the Conservative group (20 vs 10%; hazard ratio 1.94 [0.90–4.19]). In the per-protocol analysis, the primary endpoint remained insignificantly different (11% vs 7%; hazard ratio 2.01 [0.72–5.57]), but the conservative approach had a higher MACCE risk (20% vs 7%; hazard ratio 2.88 [1.24–6.68]).
Conclusion
This trial found no significant difference in the primary endpoint but observed a trend of higher MACCE in the conservative arm. Graphical Abstract A graphical abstract illustrating the key highlights of the design and comparisons
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Heart Center Graz, Medical University Graz, Graz, Austria.
- Division of Angiology, Department of Internal Medicine, Medical University Graz, Graz, Austria.
- Department of Cardiology, Faculty of Medicine, Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.
- Royal Cornwall Hospitals NHS Trust, Truro, UK.
- II Dept of Cardiology, Medical College, Jagiellonian University, Krakow, Poland.
- Department of Cardiology, University of Zagreb School of Medicine, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Zitieren
APA
Toth, G. G., Brodmann, M., Kanoun Schnur, S. S., Bartus, S., Vrsalovic, M., Krestianinov, O., Kala, P., Bil, J., Gil, R., Kanovsky, J., Di Serafino, L., Paolucci, L., Barbato, E., Mangiacapra, F., & Ruzsa, Z. (2025). Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02487-2
Vancouver
Toth GG, Brodmann M, Kanoun Schnur SS, Bartus S, Vrsalovic M, Krestianinov O, et al. Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02487-2
BibTeX
@article{Toth2025,
author = {Toth, Gabor G and Brodmann, Marianne and Kanoun Schnur, Sadeek S and Bartus, Stanislaw and Vrsalovic, Mislav and Krestianinov, Oleg and Kala, Petr and Bil, Jacek and Gil, Robert and Kanovsky, Jan and Di Serafino, Luigi and Paolucci, Luca and Barbato, Emanuele and Mangiacapra, Fabio and Ruzsa, Zoltan},
title = {Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial},
journal = {Clinical Research in Cardiology},
year = {2025},
doi = {10.1007/s00392-024-02487-2}
}
EUVIMED